Weidong Ren Selected Research

Tirofiban (Aggrastat)

1/2015

Clinical research of treatment with tirofiban for high-risk non-ST-segment elevation acute coronary syndrome during peri-operative intervention operation period.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Weidong Ren Research Topics

Disease

8	Neoplasms (Cancer) 03/2022 - 10/2012
6	Breast Neoplasms (Breast Cancer) 11/2022 - 12/2016
3	Inflammation (Inflammations) 01/2023 - 04/2020
3	Hypoxia (Hypoxemia) 01/2020 - 12/2016
3	Stomach Neoplasms (Stomach Cancer) 01/2018 - 11/2015
2	Hypertension (High Blood Pressure) 01/2023 - 01/2023
2	Glucose Intolerance 01/2023 - 05/2019
2	Type 2 Diabetes Mellitus (MODY) 12/2022 - 05/2019
2	Hepatocellular Carcinoma (Hepatoma) 03/2022 - 04/2015
2	Stomach Ulcer (Gastric Ulcer) 01/2022 - 01/2017
2	Hemorrhage 01/2022 - 07/2019
2	Thrombosis (Thrombus) 01/2022 - 01/2022
2	Constrictive Pericarditis 04/2020 - 11/2018
1	Glioma (Gliomas) 10/2023
1	Hyperglycemia 12/2022
1	Carcinogenesis 11/2022
1	Anaphylaxis (Anaphylactic Shock) 01/2022
1	Anemia 01/2022
1	Duodenal Ulcer (Curling's Ulcer) 01/2022
1	Gastritis 01/2022
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2022
1	Myocardial Infarction 01/2022
1	Stroke (Strokes) 01/2022
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	Adenoma (Adenomas) 01/2021
1	Fibrosis (Cirrhosis) 04/2020
1	Pancreatitis 01/2020
1	Varicose Veins (Varicose Vein) 01/2020
1	Insulin Resistance 05/2019
1	Dyspnea (Shortness of Breath) 01/2018
1	Contracture 01/2017
1	Ulcer 01/2017
1	Glycogen Storage Disease Type II (Pompe's Disease) 04/2015
1	Acute Coronary Syndrome 01/2015
1	Coronary Disease (Coronary Heart Disease) 01/2015
1	Cysts 07/2013

Drug/Important Bio-Agent (IBA)

4	Contrast MediaIBA 01/2020 - 11/2015
4	CelluloseIBA 01/2020 - 11/2015
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 05/2019
2	MicroRNAs (MicroRNA)IBA 10/2023 - 11/2022
2	Biomarkers (Surrogate Marker)IBA 11/2022 - 04/2020
2	Oxygen (Dioxygen)IBA 08/2020 - 01/2020
1	Sincalide FDA Link 10/2023
1	Antihypertensive Agents (Antihypertensives)IBA 01/2023
1	Triglycerides (Triacylglycerol)IBA 01/2023
1	Cholinergic Agents (Cholinergics)IBA 01/2023
1	Liposomes (Liposome)IBA 12/2022
1	LipopolysaccharidesIBA 12/2022
1	Clodronic Acid (Clodronate)IBA 12/2022
1	N 30IBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 01/2021
1	AldosteroneIBA 01/2021
1	Circular RNAIBA 04/2020
1	Competitive Endogenous RNAIBA 04/2020
1	shengjingIBA 01/2020
1	ParaffinIBA 01/2020
1	IntegrinsIBA 01/2020
1	Twist-Related Protein 1IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 05/2019
1	Glucagon-Like Peptide 1 (GLP 1)IBA 05/2019
1	Blood Glucose (Blood Sugar)IBA 05/2019
1	Toll-Like Receptor 4IBA 05/2019
1	transcription factor NF-AT c3IBA 01/2019
1	CollagenIBA 01/2019
1	CalciumIBA 11/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	ElementsIBA 01/2017
1	Small Interfering RNA (siRNA)IBA 12/2016
1	GlucosidasesIBA 04/2015
1	AcidsIBA 04/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2015
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2015
1	Tirofiban (Aggrastat)FDA Link 01/2015
1	contrast agent BR1IBA 10/2012
1	SuspensionsIBA 10/2012

Therapy/Procedure

5	Neoadjuvant Therapy 08/2020 - 12/2016
3	Oral Administration 01/2020 - 11/2015
2	Radiofrequency Ablation 03/2022 - 04/2015
2	Therapeutics 01/2018 - 01/2017
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 12/2022
1	Bariatric Surgery 12/2022
1	Stents 01/2022
1	Secondary Prevention 01/2022
1	Decompression 01/2020
1	Enteral Nutrition (Feeding, Tube) 01/2020
1	Length of Stay 07/2019
1	Gastrectomy 01/2017
1	Conservative Treatment 07/2013
1	Local Anesthesia 10/2012